The UK’s Financial Conduct Authority’s (FCA) review of the impact on research is too early and too late.
It has launched a review into the application of the EU’s Markets in Financial Instruments Directive (Mifid II) regulations and the unbundling of research costs. This comes nearly six months after Mifid II came into effect at the beginning of this year but long before its impact on the market becomes anything close to clear.
RSRCHXchange’s findings in its latest buy-side survey shed some light on investor attitudes to the changes.
Thanks for your interest in Euromoney!
To unlock this article: